| Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial | |
| Tan Bei; Luo Han-Qing; Xu Hong; Lv Nong-Hua; Shi Rui-Hua; Luo He-Sheng; Li Jian-Sheng; Ren Jian-Lin; Zou Yi-You; Li Yan-Qing | |
| 2017 | |
| 卷号 | 12期号:4页码:e0175625 |
| ISSN号 | 1932-6203 |
| DOI | 10.1371/journal.pone.0175625 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6367868 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Tan Bei,Luo Han-Qing,Xu Hong,et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial[J],2017,12(4):e0175625. |
| APA | Tan Bei.,Luo Han-Qing.,Xu Hong.,Lv Nong-Hua.,Shi Rui-Hua.,...&Qian Jia-Ming.(2017).Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.,12(4),e0175625. |
| MLA | Tan Bei,et al."Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial".12.4(2017):e0175625. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论